COVERAGE: Part D Contingency Plans For Dual Eligibles Still Riddled With Pitfalls

Why This Topic Matters

The article highlights potential coverage disruption during a major Medicare transition affecting beneficiaries who rely on uninterrupted access to medications. It matters to policymakers, payers, pharmacies, and compliance teams monitoring whether contingency processes are adequate for vulnerable populations.

Article Sections

1. Congress Shows Growing Concern

   Introduces the policy and oversight concerns prompting review of the transition process for dual eligibles. Summarizes the questions raised about coverage continuity and administrative readiness.

2. 3 Problem Areas Leave Room For Coverage Gaps

   Outlines the broad categories of transition risk identified in the report. Focuses on data, timing, and access issues that could affect coverage continuity.

3. Automatic Enrollment Contingency Leaves Pharmacies With Scant POS Preparations

   Discusses the contingency approach tied to point-of-sale enrollment and implementation readiness. Covers pharmacy education, vendor timing, and operational coordination concerns.

4. Pharmacies Unprepared To Invoke Eligibility Transaction

   Addresses the information-technology process intended to help pharmacies identify coverage details. Notes concerns about awareness and practical use by dispensing locations.

5. First-Fill Contingency Doesn't Preclude Out-Of-Pocket Expenses

   Reviews the backup approach for initial prescription access when a drug is not available through a plan’s standard coverage. Also discusses the limits of this backup from the report’s perspective.

6. Financial Disincentives Cause Many States To Pass On Medicaid Refill Option

   Covers the optional state Medicaid refill flexibility described in the article. Focuses on why some states may not participate in the transition assistance measure.

7. CMS Offers Prickly Defense

   Summarizes CMS’s response to the report and its defense of the contingency framework. Includes CMS’s disagreement with the report’s framing and requested revisions.